BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17690559)

  • 21. Is overexpression of TWIST, a transcriptional factor, a prognostic biomarker of head and neck carcinoma? Evidence from fifteen studies.
    Zhuo X; Luo H; Chang A; Li D; Zhao H; Zhou Q
    Sci Rep; 2015 Dec; 5():18073. PubMed ID: 26656856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of the chromatin remodeling factor Rsf-1 is upregulated in ovarian carcinoma effusions and predicts poor survival.
    Davidson B; Trope' CG; Wang TL; Shih IeM
    Gynecol Oncol; 2006 Dec; 103(3):814-9. PubMed ID: 16844205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Twist expression in patients with cervical cancer is associated with poor disease outcome.
    Shibata K; Kajiyama H; Ino K; Terauchi M; Yamamoto E; Nawa A; Nomura S; Kikkawa F
    Ann Oncol; 2008 Jan; 19(1):81-5. PubMed ID: 17925286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.
    Osada R; Horiuchi A; Kikuchi N; Yoshida J; Hayashi A; Ota M; Katsuyama Y; Melillo G; Konishi I
    Hum Pathol; 2007 Sep; 38(9):1310-20. PubMed ID: 17555795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of TWIST and E-cadherin expression in the metastatic progression of prostatic cancer.
    Yuen HF; Chua CW; Chan YP; Wong YC; Wang X; Chan KW
    Histopathology; 2007 Apr; 50(5):648-58. PubMed ID: 17394502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 and mdm2 as prognostic indicators in patients with epithelial ovarian cancer: a multivariate analysis.
    Dogan E; Saygili U; Tuna B; Gol M; Gürel D; Acar B; Koyuncuoğlu M
    Gynecol Oncol; 2005 Apr; 97(1):46-52. PubMed ID: 15790436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer.
    Borgoño CA; Kishi T; Scorilas A; Harbeck N; Dorn J; Schmalfeldt B; Schmitt M; Diamandis EP
    Clin Cancer Res; 2006 Mar; 12(5):1487-93. PubMed ID: 16533772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma.
    Elloul S; Elstrand MB; Nesland JM; Tropé CG; Kvalheim G; Goldberg I; Reich R; Davidson B
    Cancer; 2005 Apr; 103(8):1631-43. PubMed ID: 15742334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of intranuclear inclusions is useful for the cytological diagnosis of ovarian clear cell carcinoma.
    Naka M; Ohishi Y; Kaku T; Watanabe S; Tamiya S; Ookubo F; Kato K; Oda Y; Sugishima S
    Diagn Cytopathol; 2015 Nov; 43(11):879-84. PubMed ID: 26219930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and significance of TWIST basic helix-loop-helix protein over-expression in gastric cancer.
    Yan-Qi Z; Xue-Yan G; Shuang H; Yu C; Fu-Lin G; Fei-Hu B; Shi-Ren S; Xu-Feng W; Jie D; Dai-Ming F
    Pathology; 2007 Oct; 39(5):470-5. PubMed ID: 17886095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of autophagy protein LC3A as a therapeutic target in ovarian clear cell carcinomas.
    Miyamoto M; Takano M; Aoyama T; Soyama H; Yoshikawa T; Tsuda H; Furuya K
    J Gynecol Oncol; 2017 May; 28(3):e33. PubMed ID: 28382796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High Twist expression is involved in infiltrative endometrial cancer and affects patient survival.
    Kyo S; Sakaguchi J; Ohno S; Mizumoto Y; Maida Y; Hashimoto M; Nakamura M; Takakura M; Nakajima M; Masutomi K; Inoue M
    Hum Pathol; 2006 Apr; 37(4):431-8. PubMed ID: 16564917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical significance of twist expression in nasopharyngeal carcinoma.
    Song LB; Liao WT; Mai HQ; Zhang HZ; Zhang L; Li MZ; Hou JH; Fu LW; Huang WL; Zeng YX; Zeng MS
    Cancer Lett; 2006 Oct; 242(2):258-65. PubMed ID: 16412561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study.
    Davidson B; Gotlieb WH; Ben-Baruch G; Kopolovic J; Goldberg I; Nesland JM; Berner A; Bjåmer A; Bryne M
    Gynecol Oncol; 2000 Apr; 77(1):35-43. PubMed ID: 10739688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced expression of Annexin A4 in clear cell carcinoma of the ovary and its association with chemoresistance to carboplatin.
    Kim A; Enomoto T; Serada S; Ueda Y; Takahashi T; Ripley B; Miyatake T; Fujita M; Lee CM; Morimoto K; Fujimoto M; Kimura T; Naka T
    Int J Cancer; 2009 Nov; 125(10):2316-22. PubMed ID: 19598262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival analysis of ovarian clear cell carcinoma confined to the ovary with or without comprehensive surgical staging.
    Takano M; Sasaki N; Kita T; Kudoh K; Fujii K; Yoshikawa T; Kato M; Hirata J; Furuya K; Tsuda H; Kikuchi Y
    Oncol Rep; 2008 May; 19(5):1259-64. PubMed ID: 18425385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative analysis of Napsin A, alpha-methylacyl-coenzyme A racemase (AMACR, P504S), and hepatocyte nuclear factor 1 beta as diagnostic markers of ovarian clear cell carcinoma: an immunohistochemical study of 279 ovarian tumours.
    Fadare O; Zhao C; Khabele D; Parkash V; Quick CM; Gwin K; Desouki MM
    Pathology; 2015 Feb; 47(2):105-11. PubMed ID: 25551297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of podoplanin in epithelial ovarian carcinomas and its potential as a marker for clear cell adenocarcinoma.
    Oe S; Hasegawa K; Nagase S; Kato R; Torii Y; Udagawa Y
    Int J Gynecol Pathol; 2010 Sep; 29(5):405-10. PubMed ID: 20736762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic role of E-cadherin in patients with advanced serous ovarian cancer.
    Bačić B; Haller H; Mrklić I; Košta V; Čarić A; Tomić S
    Arch Gynecol Obstet; 2013 Jun; 287(6):1219-24. PubMed ID: 23269354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunocytochemistry for hepatocyte nuclear factor-1beta (HNF-1beta): a marker for ovarian clear cell carcinoma.
    Kato N; Toukairin M; Asanuma I; Motoyama T
    Diagn Cytopathol; 2007 Apr; 35(4):193-7. PubMed ID: 17351940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.